FOCUS SHORT

Mitsui Sumitomo in Slovakia

MITSUI Sumitomo Insurance Group (MSIG) has opened an office in Slovakia, Mitsui Sumitomo Slovakia. The Slovak unit is the insurer's first completely functional office in central and eastern Europe. It started operating fully on April 1, 2009.

MITSUI Sumitomo Insurance Group (MSIG) has opened an office in Slovakia, Mitsui Sumitomo Slovakia. The Slovak unit is the insurer's first completely functional office in central and eastern Europe. It started operating fully on April 1, 2009.

The group said it considers its Slovak subsidiary essential for the region. The group plans future expansion into the Czech Republic, Hungary, and possibly Poland, but Slovakia will serve as its hub for operations in the region, the SITA newswire wrote.

The company is engaged in corporate insurance activities including insurance of property, technical risks and liability, as well as transport insurance.

Representatives of the group say they are confident about their decision to open a unit in Slovakia during a period of economic crisis.

Branch manager Dušan Smoleňák said that some insurance companies may be facing problems in Slovakia but this mainly affects life insurance.

“We are not considering life insurance services, we are exclusively a non-life insurer,” he said. “The crisis and the problem of ordinary people cancelling their insurance policies therefore do not concern us.”

Mitsui Sumitomo Insurance Group is a leading provider of general insurance solutions. Its 300 offices located in 40 countries outside Japan deal mainly in non-life insurance activities. It provides life insurance mainly in Japan and other Asian countries.


Get daily Slovak news directly to your inbox

Theme: Finances and Advisory

Read more articles by the topic

Top stories

News digest: What Jankovská said and Kollár goes home amid scandal

Nationwide testing put on hold. Speaker of parliament received visitors in hospital despite a ban. Foreigners' Police change office hours around Christmas.

Speaker of Parliament Boris Kollár

Developed at home, the production of Slovakia's COVID-19 vaccine will move abroad

Neuroimmunologist Norbert Žilka oversees the development of the ACvac1 vaccine at Axon Neuroscience.

Norbert Žilka is the director of the Institute of Neuroimmunology of the Slovak Academy of Sciences (SAV) and also the scientific director of Axon Neuroscience.